Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (Protein)

Uniprotkb:Q09327

Id:04129557-cebe-5703-becd-3d811e555723

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase 's neighborhood in the knowledge graph.

Submit

Protein Knowledge Network

The Protein Knowledge Network (ProKN) integrates protein-centric data with the genomic-centric datasets of the CFDE. Find out more about Q09327.

Submit

Results found

Linked to

	Label	Description
	N-(2-(4-Fluorophenyl)-2H-1,2,3-triazol-4-yl)-2-(2-(3-methoxyphenyl)acetyl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	GLYGEN.GLYCOSYLATION:RXN00000130 CUI has enzyme protein Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase has isoform UNIPROTKB.ISOFORM:Q09327-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLTRANSFERASE.REACTION:RXN00000128 CUI has enzyme protein Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	N-(2-Isopropyl-2H-1,2,3-triazol-4-yl)-2-(2-(3-methoxyphenyl)-acetyl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	2-(2-(3-Methoxyphenyl)acetyl)-N-(2-phenyl-2H-1,2,3-triazol-4-yl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-(2-(3,3-Difluorocyclobutyl)-2H-1,2,3-triazol-4-yl)-2-(2-(3-methoxyphenyl)acetyl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	2-(2-(3-Methoxyphenyl)acetyl)-N-(2-(tetrahydro-2H-pyran-4-yl)-2H-1,2,3-triazol-4-yl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(S)-N-(4-(difluoromethoxy)phenyl)-3-ethyl-3-methyl-2,5-dioxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	2-(2-(3-Methoxyphenyl)acetyl)-N-(2-(oxetan-3-yl)-2H-1,2,3-triazol-4-yl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

N-(2-(4-Fluorophenyl)-2H-1,2,3-triazol-4-yl)-2-(2-(3-methoxyphenyl)acetyl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

GLYGEN.GLYCOSYLATION:RXN00000130 CUI has enzyme protein Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase has isoform UNIPROTKB.ISOFORM:Q09327-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

GLYCOSYLTRANSFERASE.REACTION:RXN00000128 CUI has enzyme protein Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

N-(2-Isopropyl-2H-1,2,3-triazol-4-yl)-2-(2-(3-methoxyphenyl)-acetyl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

2-(2-(3-Methoxyphenyl)acetyl)-N-(2-phenyl-2H-1,2,3-triazol-4-yl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

N-(2-(3,3-Difluorocyclobutyl)-2H-1,2,3-triazol-4-yl)-2-(2-(3-methoxyphenyl)acetyl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

2-(2-(3-Methoxyphenyl)acetyl)-N-(2-(tetrahydro-2H-pyran-4-yl)-2H-1,2,3-triazol-4-yl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

(S)-N-(4-(difluoromethoxy)phenyl)-3-ethyl-3-methyl-2,5-dioxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

2-(2-(3-Methoxyphenyl)acetyl)-N-(2-(oxetan-3-yl)-2H-1,2,3-triazol-4-yl)isoindoline-5-sulfonamide bioactivity Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.